Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Collectively declared rate

25.63%

Threshold

Crossed upwards

Timeline

Published

29.01.2013

Transaction

21.01.2013

Voting rights breakdown

Voting rights acquired25.63%

Voting rights sold0%

Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBD1S00057

Beneficial owner

GEFIM SPA

Declared address

GEFIM SPA, 20122 - Milan

Execution of a shareholder's agreement

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.29.01.2013TBD1S00057

Disclosure summary

GEFIM SPA disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 29.01.2013, at 25.63% of voting rights. The filing groups 2 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

2 people

25.63%

Voting rights acquired

Voting rights acquired25.63%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 2 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

GEFIM SPA disclosed a holding in Newron Pharmaceuticals S.p.A., published on 29.01.2013.

Publication date29.01.2013

Transaction date21.01.2013

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerGEFIM SPA

Declared addressGEFIM SPA, 20122 - Milan

CategoryGroup of shareholders

Voting rights acquired25.63%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBD1S00057

Conditions

Execution of a shareholder's agreement

Source: SIX Exchange Regulation · Publication date: 29.01.2013

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open